在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

SE Asia a step nearer to making homegrown shots

By YANG HAN and PRIME SARMIENTO in Hong Kong | China Daily | Updated: 2021-08-30 07:44
Share
Share - WeChat
Indonesian students receive a dose of COVID-19 vaccine during a vaccination program for students in Bogor on the outskirts of Jakarta on Saturday. ANTARA FOTO/ARIF FIRMANSYAH/REUTERS

Amid a global shortage of vaccines and a new wave of COVID-19 infections, some countries in Southeast Asia are rushing to develop their own coronavirus shots.

After promising results from the phase 1 clinical trial of the experimental vaccine ChulaCov19, researchers at Chulalongkorn University in Thailand began the phase 2a trial on 150 volunteers on Thursday, on track to become Southeast Asia's first mRNA vaccine.

The vaccine "can induce a very strong antibody response, (which is) as good as Pfizer", said Kiat Ruxrungtham, director of the Chula-Cov19 mRNA vaccine development program and founder of the Chula Vaccine Research Center, the research team behind ChulaCov-19.

Unlike inactivated vaccines that contain a protein or other small pieces taken from a virus, mRNA vaccines prompt the human body to make a protein that triggers an immune response.

According to the results made public on Aug 16, based on the phase 1 trial on 36 volunteers, ChulaCov19 can 94 percent block viral binding of SARS-CoV-2, the virus that causes COVID-19, to human cells, which is similar to that of Pfizer. It can build immunity against four virus variants namely Alpha, Beta, Gamma and Delta.

T-cell response

"The vaccine is also able to induce a strong T-cell response," Kiat said. T-cell response plays a vital role in getting rid of infected cells and reducing virus in the tissues.

After the phase 2a trial, Kiat said, there will be a phase 2b trial on 5,000 volunteers in October and then possibly a phase 3 trial on 15,000 to 30,000 volunteers.

He hopes Thai authorities can consider easing the regulations on Thai-made vaccines and approve the team's vaccine for emergency use without phase 3 trial results as long as the vaccine's safety and efficacy can be proved, he said.

Kiat hopes the team's vaccine can be approved for emergency use before the Thai new year in April.

In Indonesia, the country's Food and Drug Monitoring Agency has allowed Airlangga University and PT Biotis to further develop the homegrown COVID-19 vaccine Merah Putih.

The chairwoman of the agency, Penny Lukito, said on Aug 18 that the joint research by the university and Biotis is the most promising among the six domestic institutions and universities taking part in developing the Merah Putih vaccine.

The university and Biotis are developing an inactivated vaccine in which researchers culture virus particles in the laboratory and later kill them to destroy their disease-producing capacity.

They have already concluded animal trials and may soon start human clinical trials.

Lukito said the agency may issue emergency-use authorization by the first half of next year.

"The journey (of developing homegrown vaccine) is still quite long," said Irma Hidayana, co-founder of Lapor COVID-19, a data monitoring group in Jakarta. "Merah Putih can't help the vaccination program in a very near future as we immediately need the supply now."

Indonesia's vaccination program was launched in January with the aim of inoculating 181.5 million people this year.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚洲综合在线一区 | 天天色天天色 | 99久久精品一区二区 | 成人免费视频观看视频 | 亚洲久草| 精品国产免费久久久久久尖叫 | 香蕉国产| 中文字幕日韩欧美 | 欧美一区二区三区aa大片漫 | 国产精品成av人在线视午夜片 | 日韩视频在线播放 | 亚洲啊v在线| 日本少妇xxxx软件 | 午夜激情电影在线 | 亚洲美女视频在线观看 | 国产精品久久久久国产a级 日韩在线二区 | 久久www免费人成看片高清 | 激情三区 | 欧美精品免费在线 | 国产精品99久久久久久www | 中文字幕av亚洲精品一部二部 | 国产aaa一级毛片 | 日韩精品一区二区三区在线观看 | 日本久久精品电影 | 91高清在线观看 | 亚洲成人一区二区三区 | 黄色片在线免费观看 | 日韩精品一区二区三区四区视频 | 操操操操操 | 日本在线高清 | 一级黄色片网址 | 成人aaaa| 国产精品999 | 国产视频一区二区 | 午夜视频在线播放 | 国产精品1区2区 | 久久久久久久 | 亚洲欧美日韩国产一区 | 日本三级在线观看中文字 | 日韩一区二区在线观看视频 | 日韩一区二区精品葵司在线 |